Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
9.89
-0.14 (-1.40%)
Mar 30, 2026, 1:45 PM CST

SHA:603229 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8,3088,2957,8349,56410,4518,765
Market Cap Growth
14.88%5.87%-18.09%-8.49%19.25%170.38%
Enterprise Value
7,5497,5727,1159,1839,8488,455
Last Close Price
10.039.889.2211.8012.8810.78
PE Ratio
45.3140.1130.8640.6471.62100.93
Forward PE
37.8516.2922.5834.8754.3411.21
PS Ratio
11.0610.439.5912.5118.3521.42
PB Ratio
3.543.653.666.558.337.78
P/TBV Ratio
3.783.923.947.369.588.35
P/FCF Ratio
57.77124.50134.20--192.56
P/OCF Ratio
34.3846.6235.3279.3360.1063.30
EV/Sales Ratio
10.059.528.7112.0117.2920.66
EV/EBITDA Ratio
34.1030.5024.9638.3254.0462.95
EV/EBIT Ratio
53.4040.7829.1044.7564.7077.65
EV/FCF Ratio
52.50113.66121.89--185.75
Debt / Equity Ratio
0.160.120.140.170.090.04
Debt / EBITDA Ratio
1.701.091.061.010.600.31
Debt / FCF Ratio
2.624.095.19--0.90
Net Debt / Equity Ratio
-0.32-0.36-0.38-0.25-0.45-0.62
Net Debt / EBITDA Ratio
-3.44-3.33-2.88-1.55-3.10-5.20
Net Debt / FCF Ratio
-5.28-12.40-14.062.454.12-15.34
Asset Turnover
0.250.270.310.370.350.36
Inventory Turnover
0.920.981.091.321.210.97
Quick Ratio
2.131.921.631.011.403.22
Current Ratio
2.842.532.171.531.924.02
Return on Equity (ROE)
7.96%9.37%14.09%17.33%12.25%9.80%
Return on Assets (ROA)
2.91%3.91%5.80%6.17%5.91%6.00%
Return on Invested Capital (ROIC)
7.71%11.56%17.71%21.20%24.91%25.49%
Return on Capital Employed (ROCE)
5.80%8.00%11.20%13.10%11.60%9.60%
Earnings Yield
2.22%2.49%3.24%2.46%1.40%0.99%
FCF Yield
1.73%0.80%0.74%-1.58%-1.31%0.52%
Dividend Yield
1.00%1.01%1.00%0.48%0.29%0.21%
Payout Ratio
48.89%40.73%22.63%16.00%13.69%15.43%
Buyback Yield / Dilution
-3.53%-0.99%-1.92%-1.16%-6.67%-0.25%
Total Shareholder Return
-2.53%0.02%-0.92%-0.68%-6.38%-0.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.